Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

8 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to elucidate the pharmacokinetics and the blood-brain barrier penetration of the elemene.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Elemene pharmacokinetics Blood-brain barrier

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* histopathological or cytopathology diagnosis of malignancy
* heart, liver and renal function is normal
* Expected survival time is more than 3 months
* Signed informed consent

Exclusion Criteria

* non cancer patient
* accepted elemene administration in 1 month
* Expected survival time is less than 3 months
* no Signed informed consent
* heart, liver and renal function is abnormal

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

liang xiaohua, phD

Role: PRINCIPAL_INVESTIGATOR

Huashan Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Huashan Hospital of Fudan University

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ZHAN QIONG, MD

Role: CONTACT

Phone: 8621-52887162

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSZL201001

Identifier Type: -

Identifier Source: org_study_id